Daniel L Barber
Overview
Explore the profile of Daniel L Barber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
9414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCaffrey E, Barber D
Nat Microbiol
. 2025 Jan;
10(2):274-276.
PMID: 39870872
No abstract available.
2.
Baker P, Bohrer A, Castro E, Amaral E, Snow-Smith M, Torres-Juarez F, et al.
Sci Immunol
. 2024 Dec;
9(102):eadp7951.
PMID: 39642242
Severity of COVID-19 is affected by multiple factors; however, it is not understood how the inflammatory milieu of the lung at the time of SARS-CoV-2 exposure affects the control of...
3.
Mayer-Barber K, Barber D, Via L
EBioMedicine
. 2024 Oct;
109:105382.
PMID: 39366250
No abstract available.
4.
Brooks K, Nelson C, Aguilar C, Hoang T, Ortiz A, Langner C, et al.
J Virol
. 2024 Sep;
98(10):e0128824.
PMID: 39264207
SARS-CoV-2 infects the respiratory tract, but COVID-19 includes an array of non-respiratory symptoms, among them gastrointestinal (GI) manifestations such as vomiting and diarrhea. Here we investigated the GI pathology of...
5.
Nelson C, Foreman T, Fukutani E, Kauffman K, Sakai S, Fleegle J, et al.
PLoS Pathog
. 2024 Jul;
20(7):e1012339.
PMID: 38950078
The regulation of inflammatory responses and pulmonary disease during SARS-CoV-2 infection is incompletely understood. Here we examine the roles of the prototypic pro- and anti-inflammatory cytokines IFNγ and IL-10 using...
6.
Anidi I, Sakai S, Brooks K, Fling S, Wagner M, Lurain K, et al.
Open Forum Infect Dis
. 2024 Apr;
11(5):ofae183.
PMID: 38680611
Blockade of the co-inhibitory receptor PD-1 enhances antitumor responses by boosting the function of antigen-specific T cells. Although rare, PD-1 blockade in patients with cancer can lead to exacerbation of...
7.
Kaiser J, Nelson C, Liu X, Park H, Matsuoka Y, Luongo C, et al.
Nat Commun
. 2024 Apr;
15(1):3553.
PMID: 38670948
Immunization via the respiratory route is predicted to increase the effectiveness of a SARS-CoV-2 vaccine. Here, we evaluate the immunogenicity and protective efficacy of one or two doses of a...
8.
Baker P, Bohrer A, Castro E, Amaral E, Snow-Smith M, Torres-Juarez F, et al.
bioRxiv
. 2024 Apr;
PMID: 38585846
SARS-CoV-2 infection leads to vastly divergent clinical outcomes ranging from asymptomatic infection to fatal disease. Co-morbidities, sex, age, host genetics and vaccine status are known to affect disease severity. Yet,...
9.
Pranzatelli T, Perez P, Ku A, Matuck B, Huynh K, Sakai S, et al.
Res Sq
. 2024 Jan;
PMID: 38196575
Sjögren's Disease (SjD) is a systemic autoimmune disease without a clear etiology or effective therapy. Utilizing unbiased single-cell and spatial transcriptomics to analyze human minor salivary glands in health and...
10.
Amaral E, Namasivayam S, Queiroz A, Fukutani E, Hilligan K, Aberman K, et al.
Nat Microbiol
. 2023 Dec;
9(1):120-135.
PMID: 38066332
Oxidative stress triggers ferroptosis, a form of cellular necrosis characterized by iron-dependent lipid peroxidation, and has been implicated in Mycobacterium tuberculosis (Mtb) pathogenesis. We investigated whether Bach1, a transcription factor...